The Net Margin of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is -12.71%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-03-31 | -12.71% |
2023-03-31 | 2.57% |
2022-03-31 | 7.65% |
2021-03-31 | 8.86% |
2020-03-31 | 7.29% |
2019-03-31 | 9.38% |
2018-03-31 | 8.50% |
2017-03-31 | 9.97% |
2016-03-31 | 9.18% |
2015-03-31 | 7.17% |